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Heparan sulfateHeparan sulfate proteoglycans (HSPGs) are central modulators of developmental processes likely through
their interaction with growth factors, such as GDNF, members of the FGF and TGFβ superfamilies, EGF
receptor ligands and HGF. Absence of the biosynthetic enzyme, heparan sulfate 2-O-sulfotransferase (Hs2st)
leads to kidney agenesis. Using a novel combination of in vivo and in vitro approaches, we have reanalyzed
the defect in morphogenesis of the Hs2st−/− kidney. Utilizing assays that separately model distinct stages of
kidney branching morphogenesis, we found that the Hs2st−/− UB is able to undergo branching and induce
mesenchymal-to-epithelial transformation when recombined with control MM, and the isolated Hs2st null
UB is able to undergo branching morphogenesis in the presence of exogenous soluble pro-branching growth
factors when embedded in an extracellular matrix, indicating that the UB is intrinsically competent. This is in
contrast to the prevailing view that the defect underlying the renal agenesis phenotype is due to a primary
role for 2-O sulfated HS in UB branching. Unexpectedly, the mutant MM was also fully capable of being
induced in recombination experiments with wild-type tissue. Thus, both the mutant UB and mutant MM
tissue appear competent in and of themselves, but the combination of mutant tissues fails in vivo and, as we
show, in organ culture. We hypothesized a 2OS-dependent defect in the mutual inductive process, which
could be on either the UB or MM side, since both progenitor tissues express Hs2st. In light of these
observations, we speciﬁcally examined the role of the HS 2-O sulfation modiﬁcation on the morphogenetic
capacity of the UB and MM individually. We demonstrate that early UB branching morphogenesis is not
primarily modulated by factors that depend on the HS 2-O sulfate modiﬁcation; however, factors that
contribute to MM induction are markedly sensitive to the 2-O sulfation modiﬁcation. These data suggest that
key defect in Hs2st null kidneys is the inability of MM to undergo induction either through a failure of mutual
induction or a primary failure of MM morphogenesis. This results in normal UB formation but affects either
T-shaped UB formation or iterative branching of the T-shaped UB (possibly two separate stages in collecting
system development dependent upon HS). We discuss the possibility that a disruption in the interaction
between HS and Wnts (e.g. Wnt 9b) may be an important aspect of the observed phenotype. This appears to
be the ﬁrst example of a defect in the MM preventing advancement of early UB branching past the ﬁrst
bifurcation stage, one of the limiting steps in early kidney development.Diego, 9500 Gilman Drive, La
Toxicology, Kyorin University
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Heparan sulfate proteoglycans (HSPG) are critical to many
developmental and physiologic processes. HSPGs, which are abun-
dantly present in the extracellular milieu as a component of cellsurface-associated and basement membrane proteoglycans, are
modular molecules made up of a protein core coupled to a uniquely
sulfated heparan sulfate (HS) chain. HSPGs are involved in growth
factor signaling on a variety of levels. While the protein core appears
to have some role in these processes, it is believed that the sulfated HS
chains modulate growth factor gradients as well as receptor binding
and signaling (Baeg et al., 2004; Friedl et al., 2001; Fujise et al., 2003;
Kamimura et al., 2004; Reich-Slotky et al., 1994; Shah et al., 2004;
Steer et al., 2004). The tremendous diversity in HS chain sulfation
pattern is generated during biosynthesis (Esko and Lindahl, 2001). HS
glycosaminoglycans (GAGs) are characterized by a variable number of
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acid residues which can be modiﬁed through N-sulfation, N-
acetylation and O-sulfation by at least 16 biosynthetic enzymes. The
sequence of modiﬁcation is strictly governed: N-sulfation, mediated
through the N-deacetylase/N-sulfotransferase (NDST) family of
enzymes followed by epimerization of glucuronic acid to iduronic
acid by C-5 epimerase and then sulfation at the 2-O position of
iduronic acid by heparan sulfate 2-O sulfotransferase (Hs2st) and
ﬁnally 6-O sulfation and 3-O sulfation (reviewed in Esko and Lindahl,
2001). Although the enzymatic modiﬁcations occur sequentially,
some of them do not go to completion, creating unique HS chain
sulfation patterns.
Multiple lines of in vitro and in vivo evidence have shown that HS
is required for normal kidney development. The permanent mamma-
lian kidney, or metanephros, arises through an outpouching of the
Wolfﬁan duct (WD). This epithelial outpouching, termed the ureteric
bud (UB), is induced through signals emanating from a region of
adjacent intermediate mesoderm, termed metanephric mesenchyme
(MM). Through a series of mutual induction steps, the UB undergoes
elongation and branching morphogenesis to form the collecting
system of the metanephros. Simultaneously, the MM is induced to
undergo a mesenchymal-to-epithelial transition, proceeding through
a series of well-deﬁned morphologic structures, from comma- to
S-shaped bodies; these structures eventually form the more proximal
portion of the nephron, from the epithelial glomerulus to the distal
tubule (Shah et al., 2004).
Branching morphogenesis in the kidney is regulated by a variety of
heparin-binding morphogens known to regulate kidney development
including glial cell-line derived neurotrophic factor (GDNF), members
of theﬁbroblast growth factor (FGF) and TGFβ superfamilies, aswell as
HGF, EGF, pleiotrophin (PTN) andheregulin (HRG), suggesting that the
HS-growth factor interaction is important during kidney branching
morphogenesis (Lyon et al., 1997; Ornitz, 2000; Qiao et al., 1999, 2001;
Rickard et al., 2003; Sakurai et al., 2001, 2005; Ishibe et al., 2009). In
vitro perturbation of GAG sulfation or proteolytic degradation of HS in
whole embryonic kidney and isolated UB organ culture results in
disruption of normal UB branching morphogenesis, an essential
process for formation of the kidney (Lelongt et al., 1988; Davies et
al., 1995; Platt et al., 1990; Steer et al., 2004). Moreover, in vivo studies
have demonstrated that HS sulfation pattern is of central importance
to kidney development as null mutation of the HS biosynthetic
enzymes Hs2st or C-5 epimerase in mice results in a renal agenesis
phenotype (Bullock et al., 1998; Li et al., 2003). However, despite the
clear role of HS and HS sulfation pattern in kidney development, a key
question remains: Is the defect in kidney development in the mutant
mice intrinsic to the UB orMM? In the original description of theHs2st
null mutant, it was suggested that UB branching is primarily affected
by lack of HS 2-O sulfation (Wilson et al., 2002); however this
hypothesis has not yet been further investigated.
Here, we sought to clarify the role of HS 2-O sulfation in kidney
development by ﬁrst analyzing Hs2st−/− tissues in vitro. We
attempted to localize the defect in kidney development in the Hs2st
knockout mouse to the UB or the MM and unexpectedly found that
both the UB and MM are competent to undergo branching
morphogenesis and mesenchymal-to-epithelial transition when
induced by wild-type MM and UB, respectively. We then utilized
established models of in vitro kidney development to investigate the
role of 2-O sulfation in the binding of factors that modulate the
various stages of kidney development. We found that factors
regulating isolated UB branching morphogenesis are, in fact, not
sensitive to the 2-O sulfation modiﬁcation while factors modulating
early MM induction appear to be most vulnerable to 2-O sulfation
dependent effects. This represents the ﬁrst demonstration of a defect
in the transition from the ﬁrst dichotomous branching step to the
early UB branching stage by virtue of a defect in mutual inductive
signaling that primarily resides in the MM (despite itself beingcapable of being normally induced). Moreover, the data support the
view that distinct growth factor interactions with variably sulfated HS
play an important role in driving the stages of kidney development.
Materials and methods
Materials
Heparinoids (heparin and 2-O-desulfated heparin) were obtained
fromNeoparin (Alameda, CA). Tissue culturemediawere obtained from
Invitrogen (Carlsbad, CA) and fetal calf serum obtained from Biowhit-
taker (East Rutherford, NJ). Transwell ﬁlters (0.4-μm pore size) were
obtained from Costar (Corning, NY). Growth factor-reduced Matrigel
wasobtained fromBDBiosciences (SanDiego, CA). Recombinanthuman
TGF-β2, BMP-2, BMP-4, rat glial-cell-line-derived neurotrophic factor
(GDNF), FGF1, FGF2, FGF7 and FGF10 were from R&D Systems
(Minneapolis, MN). FITC-conjugated or Rhodamine-conjugated Doli-
chos biﬂorus lectin (DB) was obtained from Vector Laboratories
(Burlingame, CA). The primary antibody against E-cadherin [mouse
monoclonal, 1:1000] was from Transduction Laboratories (San Jose,
CA); secondary antibodies were from Jackson Immunoresearch Labo-
ratories (West Grove, PA) or Invitrogen. All other reagents and
chemicals, unless otherwise indicated,were from Sigma (St. Louis, MO).
Generation of knockout mice
The mouse strain used was Hs2stTgNSt125NIMRon a mixed C57Bl/6/
129Ola background, a gift from Catherine Merry (Bullock et al., 1998).
Embryonic day 1 was designated the day when the vaginal plug was
ﬁrst observed. Whole embryonic kidney and isolated WD rudiments
were isolated at E12 and isolated UB andMMwere obtained at E12 for
recombination experiments. Embryonic mice were genotyped as
previously described (Bullock et al., 1998). The care and use of
animals described in this study conform to the procedures of the
laboratory's Animal Protocol approved by the Animal Subjects
Program of the University of California, San Diego.
Culture of isolated whole embryonic kidneys
Embryonic kidneys from gestational day 12 mice or 13.5 Sprague–
Dawley rat embryos were isolated and applied to the top of Transwell
ﬁlters placed within individual wells of a 12-well tissue culture dish.
The isolated kidneys were cultured (37 °C, 5% CO2, 100% humidity) in
DMEM/F12 media supplemented with 10% fetal calf serum and
varying concentrations of heparin compound as indicated in the text.
Kidneys were cultured for 3–4 days, then ﬁxed in 4% paraformalde-
hyde and stained as indicated in the ﬁgure legend. All cultures were
performed in triplicate with n≥3 rudiments per sample.
Hs2st expression analysis
Microarray gene expression data for e11.5 mesenchyme, e11.5
ureteric bud, e15.5 uninduced mesenchyme (peripheral blastema)
and e15.5 ureteric bud tip were obtained from the GUDMAP
consortium database (www.gudmap.org). Genespring GX 7.3 was
used to obtain the expression values for the probes for Hs2st for each
of the four tissue types. Normalized intensity for each of the probes
was graphed. Statistical analysis was carried out using ANOVA.
Isolation and culture of Wolfﬁan ducts
The entire urogenital tract was isolated from timed pregnant
Sprague–Dawley rats at e13.5 or mice at e12. Kidney rudiments were
removed and the Wolfﬁan duct (WD) was isolated and stripped of
adjacent tissues except for a thin layer of surrounding intermediate
mesodermal cells as previously described (Maeshima et al., 2006).
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cultured at the air-medium interface. Cultures were carried out at 37 °C
in a fully humidiﬁed 5% CO2 atmosphere in the presence of BSN-CM
supplemented with 10% FCS, and GDNF (125 ng/ml) in the case of rat
WDorDMEM/F12 supplementedwith10%FCS, GDNF (125ng/ml), and
FGF1 (125ng/ml) in the case ofmouseWD.All cultureswereperformed
in triplicate with n≥3 rudiments per sample.
TUNEL apoptosis assay
TUNEL labeling of DNA strand breaks was performed in whole
kidney rudiments. Kidneys were ﬁxed in 1% paraformaldehyde for
30 min at RT and rinsed in PBS. TUNEL staining was then performed
according to themanufacturer's instructions (Intergen, Purchase, NY).
Counterstainingwith Lotus lectin precededmounting in Fluoromount.
Samples were evaluated by scanning laser confocal microscopy.
Generation of BSN conditioned media
The metanephric mesenchyme-derived cell line (BSN cells) was
cultured in DMEM/F12 supplemented with 10% fetal calf serum at
37 °C in an atmosphere of 5% CO2. Conditioned mediumwas collected
after incubation with serum-free DMEM/F12 for 3–4 days. After
collection, the conditioned media was concentrated approximately
ﬁve-fold, and the buffer was changed to fresh DMEM/F12media using
the Ultrasette ﬁltration device (5K MWCO; Pall; San Diego, CA).
Isolation and culture of UB
Isolated UB cultures were performed as previously described (Qiao
et al., 1999) with slight modiﬁcations. Brieﬂy, E13 rat or E11 mouse
kidneys were lightly digested with trypsin and the UBs separated from
the MM using ﬁne-tipped needles. The UBs were suspended in
Transwell ﬁlters within a matrix containing growth factor-reduced
Matrigel diluted1:1withDMEM/F12media. The isolatedUBswere then
cultured in BSN-CM supplemented with 10% FCS, 125 ng/ml GDNF and
125–375 ng/ml FGF1 and varying concentrations of heparinoid as
indicated in the text. UBswere allowed to grow for 6–7days. All cultures
were performed in triplicate with n≥3 rudiments per sample.
Recombination of Hs2st null and wild-type tissues
Hs2st null UB and MM and wild-type UB and MM were obtained
from E12 embryos. Hs2st null tissues were identiﬁed by kidney
rudiments that failed to undergo branching morphogenesis and were
subsequently conﬁrmed via PCR genotyping. UB and MM were
isolated as described above. For mix-and-match experiments, Hs2st
null UBs were recombined with wild-type MM and vice versa on the
day of isolation on a Transwell ﬁlter and cultured in DMEM/F12 with
10% FCS and the culture was carried out for 5–7 days at 37 °C, 5%
humidiﬁed CO2.
Recombination of cultured UB and fresh MM
Cultured isolated rat UBs that were grown for 6–7 days were
cleanly separated from as much of the surrounding matrix as possible
and placed on top of a Transwell ﬁlter in close proximity to freshly
isolated E13 rat MM. DMEM/F12 with 10% FCS was added to the well
and the culture was carried out at 37 °C, 5% humidiﬁed CO2 as
previously described (Qiao et al., 1999; Steer et al., 2002). All cultures
were performed in triplicate with n≥2 replicates per experiment.
Immunohistochemistry and confocal analysis
Isolated UB grown in extracellular matrix gels or whole cultured
kidneys were ﬁxed in 4% paraformaldehyde (EM Sciences, FortWashington, PA) for 30 min at room temperature and then washed
with PBS. UBs were dissected from the Transwell insert and excess
extracellular matrix gel was removed. Immunohistochemistry was
performed as previously described (Meyer et al., 2004). Peanut
agglutinin (PNA) lectin staining after tissue incubation with neur-
aminidase was carried out as previously described (Qiao et al., 1999).
Specimens were examined by scanning laser confocal microscopy
(NikonD-Eclipse C1). Imageswere processedwith Photoshop software
(Adobe, San Jose, CA).
Image analysis and statistics
Geometric and quantitative measurement of the tissues was
performed using Image Pro Plus. UB tips within cultured embryonic
kidneys were visualized by staining with ﬂuorescein-conjugated
Dolichos biﬂorus lectin (1:100). Each assay was performed in at least
triplicate, and data are presented as mean values+S.D. The ANOVA
single factor test was applied to data from the experiments. A p value
of b0.05 was accepted to indicate statistical signiﬁcance.
Results
Whole Hs2st null kidney rudiments fail to develop in vitro, indicating an
intrinsic kidney defect
In the absence of the HS biosynthetic enzyme, Hs2st, kidney
agenesis results with 100% penetrance (Bullock et al., 1998)
suggesting that HS modiﬁcations are critical for the formation of the
kidney. During our analysis, we noted that approximately one-third of
the mutant kidney rudiments had undergone the ﬁrst bifurcation step
to form the T-shaped UB at e12.5 (Fig. 1), although branching is
signiﬁcantly delayed compared to wild-type. This ﬁnding is in
contrast to the originally reported phenotype of the Hs2st null
mouse (Bullock et al., 1998). Despite the initial UB branching that
occurred, renal agenesis persisted; thus as an initial step to determine
the speciﬁc location affected by loss of Hs2st (UB or MM), we ﬁrst
conﬁrmed that the primary defect is intrinsic to the kidney by
performing whole embryonic kidney culture using Hs2st−/− E12
kidney rudiments. Consistent with the in vivo phenotype, these
embryonic kidneys did not undergo branching morphogenesis or
nephron induction (irrespective of the presence of UB bifurcation)
(Figs. 2G, H) whereas wild-type (Figs. 2A, B) and heterozygous (Figs.
2D, E) rudiments grew normally. This result conﬁrmed that the defect
in kidney development is fundamental to the kidney and is not due to
extrinsic HS-mediated factors. TUNEL staining on the embryonic
kidney rudiments demonstrated there was little apoptosis noted in
either UB or MM in wild-type and heterozygous kidneys isolated at
E11.5 (Figs. 2C, F). Similarly, there was little apoptosis in knockout
kidneys (Fig. 2I). This result suggests that the underlying mechanisms
leading to the failure of kidney development likely occur in the events
that occur after UB formation (UB branching, MM induction).
Hs2st is expressed in both the UB and MM during early development
During renal development, Hs2st is initially expressed in both UB
and MM compartments but subsequently becomes localized to the
undifferentiated mesenchyme (Bullock et al., 1998). We sought to
conﬁrm these ﬁnding using the GUDMAP expression database (www.
gudmap.org). GUDMAP was developed as a repository for high
resolution analyses to deﬁne gene expression throughout kidney
development and to correlate the boundaries of gene expression with
anatomic domains; the database has now been used to show
differences in gene expression within speciﬁc kidney cell types and
has demonstrated excellent correlation with previously published
gene expression data in the UB and MM (Brunskill et al., 2008). We
conﬁrmed that the expression of Hs2st is present at e11.5 and is not
Fig. 1. Phenotypic variations of Hs2st null kidneys. At e12.5, two different ureteric bud (UB) phenotypes are noted amongst Hs2st−/− embryonic kidneys. The most common
phenotype is that of an unbranched UB (approximately two-thirds of kidneys analyzed) and the other is of a UB that has undergone the ﬁrst dichotomous branching step (T-shaped,
approximately one-third). Despite the fact that the UB has branched to a T-shape, overall branching is signiﬁcantly delayed compared to wild-type and renal agenesis occurs at a
100% penetrance rate.
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Consistent with the original report, Hs2st expression was signiﬁcantly
increased in the uninduced MM (peripheral blastema) versus the UB
tip at e15. From this expression data one cannot determine where the
primary defect occurs since kidney developmental failure occurs early
in kidney organogenesis and Hs2st is expressed in both locations atFig. 2. Embryonic kidney culture and TUNEL staining of kidney rudiments obtained from H
isolated and cultured in vitro for 6 days. Genotyping was performed following isolation. Bo
and branching patterns on culture day 2 and culture day 6. In contrast, knockout rudimen
arrow points to the ureteric bud) and by culture day 6, the metanephric mesenchyme ha
whole embryonic kidneys. Confocal micrographs of isolated wild-type (A), heterozygous (
lotus lectin (red) and DAPI (blue). There is no signiﬁcant difference in apoptosis between e
Hs2st (H).this stage. In addition, because HS proteoglycans are present either as
cell surface molecules or as components of the basement membrane,
which both cell types potentially contribute to the establishment
thereof, the precise location that is affected by loss of HS 2-O sulfation
cannot necessarily be determined by the cellular expression of the
enzyme. It has been postulated that a primary defect in UB branchings2st heterozygous matings. Phase contrast micrographs of embryonic day 12 kidneys
th wild-type (A, B) and heterozygous (D, E) kidney rudiments display normal growth
ts show no morphogenesis beyond outgrowth of the ureteric bud at culture day 2 (G;
s degenerated although the ureter remains (H). All images at 10. TUNEL staining in
B) and knockout (C) embryonic day 11.5 kidneys stained for apoptotic cells (green),
mbryonic kidneys that express Hs2st (C, F) and embryonic kidneys that are deﬁcient in
Fig. 3. Hs2st expression in ureteric bud (UB) and metanephric mesenchyme (MM) is
quantitatively similar at e11.5. Hs2st expression was analyzed using the GUDMAP
database (www.gudmap.org). At e11.5, expression of Hs2st was quantitatively similar
in the UB and MMwhile at e15.5, Hs2st expression is signiﬁcantly higher in uninduced
MM (peripheral blastema) vs. the UB tip. Average±SD, n=3, ⁎pb0.05 compared to
e15.5 UB tip.
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branching does not occur in the absence of Hs2st (Wilson et al., 2002);
however, the eventual localization of Hs2st to the mesenchymal
compartment might suggest that the defect underlying the renal
agenesis phenotype resides in the MM. Whatever the mechanism, the
knockout data suggest that Hs2st is somehow involved in the
progression from the UB budding to the iterative UB branching
stage of kidney development.
In vitro kidney epithelial morphogenesis is normal in the absence
of Hs2st
In order to resolve the above issues regarding the location of the
defect and to isolate the stage at which kidney development fails, we
utilized the mutant kidney rudiments in well-established in vitro
assay systems, which are presumed to recapitulate the steps of kidney
development based on morphology and gene expression (Qiao et al.,Fig. 4. Epithelial morphogenesis occurs in Hs2st−/−Wolfﬁan ducts (WD)and isolated urete
cultured in vitro for 3 days in DMEM/F12 supplemented with 125 ng/ml GDNF and 125 ng/m
knockout rudiments show similar levels of epithelial budding suggesting that the Hs2st null W
budding from the WD. (C–F) Phase contrast micrographs of UBs isolated from E11 kidney
presence of BSN conditioned media and 125 ng/ml GDNF and 125 ng/ml FGF1. Isolated UBs
growth and branching suggesting that the Hs2st null UB is competent to undergo branchin1999; Stuart et al., 2001, 2003; Maeshima et al., 2006; Rosines et al.,
2007; Tsigelny et al., 2008). Brieﬂy, a model of kidney collecting
system morphogenesis has been proposed in which the processes
leading to nephron formation consist of discrete and functionally
separable “stages,” some of which overlap in vivo (Monte et al., 2007;
Sampogna and Nigam, 2004; Rosines et al., 2007; Nigam and Shah,
2009; Tsigelny et al., 2008; Shah et al., 2004). These stages include UB
outgrowth from the WD, formation of the “T-shaped” UB, early UB
branching, late branching, and branching termination and tubule
maintenance. In vitro and in vivo studies suggest that these stages of
kidney collecting system development are governed by a unique set of
factors and that disruption of these processes leads to stage-speciﬁc
defects (renal agenesis, diminished nephron number, cystic kidney
disease). It is further hypothesized that speciﬁc growth factor–HS
interactions play key roles in the transition from one stage to the next
(Monte et al., 2007; Nigam and Shah, 2009; Sampogna and Nigam,
2004; Shah et al., 2004; Steer et al., 2004). These in vitro systems
enable the separate modeling of these processes related to develop-
ment of the kidney collecting system through branching (Bush et al.,
2004; Maeshima et al., 2006; Qiao et al., 1999, 2001; Rosines et al.,
2007).
We ﬁrst attempted to elucidate whether the underlying develop-
mental processes involved in UB formation (speciﬁcally: morphogen-
esis, proliferation, the ability to deliver and receive reciprocal
inductive signals) are intact in the absence of 2-O sulfated HS using
an in vitro isolated WD culture system that models prospective MM
signaling to the WD to form the UB (Maeshima et al., 2006).
Consistent with the in vivo phenotype, the isolated WD from Hs2st
null mice underwent budding similar to non-knockout counterparts
(Figs. 4A, B) suggesting that the early morphogenetic processes are
not dependent upon HS 2-O sulfation. This is in contrast to embryonic
kidney growth (inwhich the UB andMMare also both present) where
development fails (Figs. 2G, H).
We then investigated if HS 2-O sulfation plays a role in the next
stage of kidney development, robust UB branching, by analyzing MM-
independent UB branching. Initially we applied an established in vitro
model system of isolated UB branching to the Hs2st null UB toric buds (UB). (A, B) Phase contrast micrographs of embryonic day 12 WD isolated and
l FGF1. Genotyping was performed following isolation. Isolated WDs from control and
D is competent to form a ureteric bud under these conditions. Arrows point to areas of
rudiments, suspended in a three-dimensional extracellular matrix and cultured in the
from control (C, E) and knockout (D, F) rudiments show essentially the same pattern of
g morphogenesis under these conditions. All images at 10X.
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branching morphogenesis in the presence of exogenous three-
dimensional extracellular matrix and growth factors. This well-
characterized assay, in which the UB is induced to undergo robust
iterative branching morphogenesis in the absence of contact with
mesenchyme, has been fruitfully employed in the puriﬁcation of key
morphogenetic factors that affect UB branching (Bush et al., 2004;
Sakurai et al., 2001, 2005; Steer et al., 2004). Hs2st−/− UBs were
isolated at E11 and cultured in the presence of media conditioned by
MM-derived cells plus 125 ng/ml GDNF and 125 ng/ml FGF1. Under
these conditions, mutant UBs proliferated and branched in a pattern
similar to control UBs (Figs. 4C–F). These ﬁndings indicate that the
mutant UB is competent to undergo branching morphogenesis when
cultured in a suitable matrix environment and in the presence of
branch stimulatory factors (matrix and growth factors presumably
supplied by wild-type MM) and, notably, that the failure of kidney
development in the Hs2st mutant mice is not likely to be intrinsic to
the UB.
Hs2st−/− MM is capable of inducing UB branching morphogenesis and
undergoing mesenchymal-to-epithelial transformation in vitro
The above results suggest that the epithelial component of the
Hs2st null kidney rudiment is competent to undergo branching
morphogenesis. We then sought to test if MM inductive capacity
was intact by performing “mix-and-match” experiments between
mutant and wild-type/heterozygous tissues (Fig. 4). UBs and MMs
were isolated at e11.5, and mutant tissue was visually identiﬁed
through the absence/delay of UB branching. Tissue genotypewas laterFig. 5.Mix-and-match recombination culture between Hs2st knockout and control tissues. U
rudiments. Knockout tissue was visually identiﬁed by lack of UB branching morphogenesis
tissues stained with E-cadherin (green) and peanut agglutinin (red indicates podocytes) ou
show lack of mutual induction in knockout UB recombined with knockout MM (D) and U
recombined with control (wild-type) MM (A), knockout UB recombined with control (hetero
(E, F). (B, E) Epithelial structures in the recombined tissue, UB branches are noted emanating
(C, F) High power images of B, E showing pre-glomerular structures (arrows-podocytes) deconﬁrmed via PCR. Consistent with the above results demonstrating
UB competence, control MM was able to induce branching morpho-
genesis of Hs2st−/− UBs, and these mutant UBs were able to induce
mesenchymal-to-epithelial transition of the control MM (Fig. 5B)
suggesting that the UB's transformative and inductive properties are
intact even in the absence of Hs2st within the UB; thus it appears that
factors that modulate early UB branching are either not dependent
upon 2-O sulfated HS or their effects are mediated through a non-cell
autonomous mechanism. Surprisingly, a similar result was noted
when Hs2st−/− MM was recombined with control UB (Fig. 5C)
indicating that MM lacking 2-O sulfated HS is also competent to
undergo mesenchymal-to-epithelial transition in the presence of
wild-type HS provided by the UB.
Together, these results demonstrate that, in isolation (WD and
UB) or in the presence of wild-type HS provided by the UB (MM),
each Hs2st−/− progenitor compartment is competent to undergo its
speciﬁed morphogenetic program suggesting that 2-O sulfated HS is
not required for these intrinsic events. Interestingly, we noted a
difference in inductive capacity when UB and MM were obtained
from kidney rudiments that had not undergone the ﬁrst UB
bifurcation event. Unlike the UB and MM from Hs2st−/− embryonic
kidneys that had a T-shaped UB, neither UB nor MM obtained from
kidney rudiments with an unbranched UB was able to induce their
respective control tissue. Thus, it appears that these separate stages
of kidney development (formation of the T-shaped UB and iterative
UB branching) have varying sensitivity to 2-O sulfated HS, a topic
worthy of further study. These results suggest that factors that
modulate early iterative UB branching are most sensitive to this HS
modiﬁcation.reteric buds (UB) and metanephric mesenchyme (MM) were isolated from E12 kidney
and tissue genotype was later conﬁrmed via PCR. Confocal micrographs of recombined
tline epithelial (green, UB and MM derived) and mesenchymal (red) structures. Images
B branching and mesenchymal-to-epithelial transformation in control (wild-type) UB
zygous) MM (B, C), and control (heterozygous) UB recombined with knockout MM, and
from the common ureter Insets show tissue with both green and red channels displayed.
rived from the MM. Scale bars, 100 μm.
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varying sensitivity to the heparin 2-O sulfation modiﬁcation
Given the above results demonstrating that each progenitor tissue
of the Hs2st null kidney rudiment is intrinsically capable of
undergoing its speciﬁed morphogenetic program, it seems reasonable
to posit that the mechanism underlying the renal agenesis phenotype
is due to altered HS modulation of growth factor activity, since HS is
primarily involved in the binding of growth factors in developing
tissues (Garner et al., 2008; Iwao et al., 2009; Makarenkova et al.,
2009; Steer et al., 2004). We therefore sought to clarify the role of 2-O
sulfated HS on growth factors involved in embryonic kidney
development through a competition assay (schematized in Fig. 6). In
this assay, heparin or 2OS-depleted heparin are added to the media in
which the tissue of interest is cultured. 2OS-depleted heparin is
synthetically modiﬁed so that only 6-O- and N-sulfate groups on the
glucosamine moieties remain. Since heparin avidly binds many
factors, heparin (which contains 2OS moieties), within the media,
competitively binds factors away from endogenous tissue HS (either
at the cell surface or in the extracellular matrix). Thus, we compared
the effect of adding heparin versus adding 2OS-depleted heparin at
various concentrations, using tissue morphogenesis as a read out
(Fig. 6). In the case of this assay, the heparin compounds exogenously
applied to the media are not meant to substitute for endogenous HS
but rather are used to elucidate the HS binding requirement for factors
within the media that are potentially important to kidney develop-
ment. A titration curve was performed to determine if a differential
effect between heparin and 2OS-depleted heparin occurred at each
stage. If there is a concentration atwhich the addition of heparin to the
media results in inhibition of tissue morphogenesis, and the additionFig. 6. Schematic of the effect of heparin and 2OS-depleted heparin in the in vitro culture sys
and secreted by the tissue of interest (embryonic kidney, ureteric bud or metanephric me
extracellular matrix of the tissue which results in tissuemorphogenesis (blue circles represen
may be supportive for morphogenesis). Middle panel: When fully sulfated heparin (with 2-O
growth factors. The heparin competitively binds factors away from endogenous HS, thereb
heparin is added to the media (far left panel), growth factors that depend on the 2-O su
endogenous HS while those that do not depend on the 2-O sulfated moiety for binding (gre
factors are critical for tissue morphogenesis and are then able to induce morphogenesis.of 2OS-depleted heparin does not, it can be assumed that the missing
2-O sulfationmodiﬁcation is important to the binding of at least one or
more factors important to the morphogenetic event. Conversely, if the
addition of 2OS-depleted heparin also inhibits tissue morphogenesis
to the same degree as heparin does, even at low concentrations, then
the sulfation modiﬁcation is not necessary for the binding of factor(s)
critical to morphogenesis as they are still bound to the 2OS-depleted
heparin within the media (see Fig. 6, far right panel).
In vitro organ culture using 2OS depleted heparin gives results
comparable to the Hs2st−/− kidney
We ﬁrst analyzed the HS sulfation dependence of factors involved
in embryonic kidney culture. It has been previously demonstrated
that addition of 10 μg/mL of heparin is the minimum concentration at
which heparin, in the media, competitively binds growth factors and
results in signiﬁcant reduction in UB branching morphogenesis in the
whole embryonic kidney (Davies et al., 2003). A similar concentration
of 2OS-depleted heparin did not signiﬁcantly suppress UB branching,
conﬁrming that the 2OS sulfation modiﬁcation is important in the
binding of factors involved in kidney development (Fig. 7), a ﬁnding
consistent with the in vivo Hs2st−/− phenotype and organ culture of
the mutant whole kidney (Fig. 2).
Avid binding of UB branching factors does not depend on heparin
2-O sulfation
The aforementioned result in organ culture does not differentiate
whether the effect is on the UB or MM side. When heparin and 2OS-
depleted heparin were added to the media of the cultured isolated UBtem. Under control conditions (far left panel), growth factors present within the media
senchyme) are captured by heparan sulfate (HS) present on the cells and within the
t growth factors necessary for morphogenesis while the green circles are not critical but
sulfated residues, represented by the triangle) is added to themedia it binds a variety of
y trapping the factors within the media, resulting in tissue death. When 2OS-depleted
lfated moiety for binding (blue circles), will be free in the media and able to bind to
en circles) will continue to be trapped in the media. In this schematic, the blue growth
Fig. 7. (A) Heparin and 2OS-depleted heparin titration curve on embryonic kidney rudiments. Phase contrast micrographs of e13 rat embryonic kidneys that were cultured in the
presence of varying concentrations of heparin and 2OS-depleted heparin for 4–5 days. At a concentration of 10 μg/mL, heparin markedly disrupts ureteric bud (UB) branching
morphogenesis and mesenchymal induction while a similar dose of 2OS-depleted heparin has little effect on these processes. Images at 10×. (B) Graphical analysis of the average
number of UB tips as a percentage of control. UB tips were counted after staining embryonic kidneys for UB speciﬁc Dolichos biﬂoris (raw data not shown). At higher concentrations
(50 μg/mL), addition of heparin and 2OS-depleted heparin inhibits UB branching. Mean±SD, nN3, ⁎pb0.05 compared to control.
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was signiﬁcantly inhibited compared to control at all concentrations
tested (Fig. 8). This result demonstrates that both heparin and 2OS-
depleted heparin competitively bind factors that stimulate isolated UB
branching. Thus, the 2-O sulfation modiﬁcation does not appear to be
strictly required for binding of these UB branch promoting factors.
This is in marked contrast to the results from whole kidney organ
culture (in which both UB and MM are present) where there was a
signiﬁcant difference inmorphogenesis between kidneys treatedwith
heparin and 2OS-depleted heparin at a concentration of 10 μg/mL
(Fig. 7, described above). Thus, it appeared that essential factors that
stimulate isolated UB branching have a strong afﬁnity to 2OS-depleted
heparin; therefore, it seems unlikely that the Hs2st−/− phenotype
can be primarily explained by a defect in growth factor induced UB
branching. This led us to consider whether the defect lay on the MM
side.
In vitro epithelialization of the MM depends on heparin 2-O sulfation
If Hs2st−/− UB branching occurs normally in isolation from the
MM (Fig. 5) and when recombined with wild-type MM (Fig. 4C),
while being abnormal in the whole embryonic kidney in vivo and in
organ culture (Fig. 1) – and if factors that stimulate iterative
branching of the wild-type isolated UB in vitro are not strictly
dependent upon HS 2-O sulfation (Fig. 8) – then it seemed plausiblethat the defect preventing movement from the UB budding to the
iterative branching stage in the Hs2st−/− kidney resides in the
inductive capacity of the MM. We investigated this possibility by
evaluating the effect of the modiﬁed heparin on MM induction. For
these experiments, embryonic spinal cord, a known potent inducer of
MM, was placed in close contact with freshly isolated MM.
Widespread cell death without mesenchymal-to-epithelial transfor-
mation was observed in the MM/spinal cord culture (as well as organ
culture) in the presence of fully sulfated heparinwhileMM exposed to
2OS-depleted heparin underwent mesenchymal-to-epithelial transi-
tion similar to control (Fig. 9B). Since fully sulfated heparin has 2-O
sulfated residues, the marked difference in its effects compared to
2OS-depleted heparin is consistent with a key role for the 2-O sulfate
moiety in MM morphogenesis. Thus, these results suggest that the
binding of factors that stimulatemesenchymal-to-epithelial transition
are sensitive to HS 2-O sulfation and, given the insensitivity of factors
that stimulate isolated UB branching to the samemodiﬁcation (Fig. 8),
supports the view that the main defect in the Hs2st−/− kidney lies in
the role of HS to modulate growth factor activity in the MM.
MM inductive capacity for iterative UB branching morphogenesis
depends on HS 2-O sulfation
Even though factors stimulating mesenchymal-to-epithelial trans-
formation in the MM were highly sensitive to the heparin 2-O
Fig. 8. Heparin and 2OS-depleted heparin titration curve on isolated ureteric bud (UB) branching morphogenesis. (A) Phase contrast micrographs of UBs isolated from E13 kidney
rudiments, suspended in a three-dimensional extracellular matrix and cultured in the presence of BSN conditioned media and 125 ng/ml GDNF and 125 ng/ml FGF1 and varying
concentrations of heparin and 2OS-depleted heparin. Images at 10×. (B) Graphical analysis of the average number of UB tips as a percentage of control. At a concentration of 10 μg/mL
and higher, both heparin and 2OS-depleted heparin signiﬁcantly inhibit UB branching indicating that the binding of factors involved in UB branching are notmarkedly affected by the
2-O sulfate modiﬁcation. Mean±SD, nN3, ⁎pb0.05 compared to control.
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the Hs2st−/− MM could normally induce wild-type iterative UB
branching (and, as described, the mutant UB could induce wild-type
MM to undergo normal mesenchymal-to-epithelial transition and
epithelialization, Fig. 5) despite the failure of Hs2st−/− kidney
formation in vivo and in vitro (Fig. 2). This suggested that the key
role for HS 2-O sulfation lay in its role in enabling MM inductive
capacity for movement of the UB from the T-shaped phase to the
iterative branching phase of kidney development. Furthermore, it
could be argued that spinal cord is a surrogate for the natural inducer.
Therefore, we sought to address whether the natural inducer – by
way of the UB/MM recombination assay – gives consistent results. In
other words, do the factors that modulate inductive signals from the
UB to the MM that stimulate mesenchymal-to-epithelial transition
require heparin 2-O sulfation for binding? This assay takes advantage
of the ability of isolated UBs cultured or “developed” for 7 days and
freshly isolated MM to undergo mutual induction (Qiao et al., 1999;
Steer et al., 2002; Rosines et al., 2007; Shah et al., 2009). Under
control conditions (Fig. 9C), freshly isolated MM was able to induce
elongation and tapering of cultured isolated UB branches into the
MM which in turn, was induced to form comma and S-shaped bodies
as occurs in vivo during the iterative UB branching phase of kidney
development (Qiao et al., 1999; Shah et al., 2009). These segments
eventually connected to form nascent nephron units. In the presenceof fully sulfated heparin, widespread cell death was observed within
the MM and no recombination (mesenchymal-to-epithelial transi-
tion plus connection of UB and MM structures) took place (Fig. 9C,
far right panel). This is consistent with the results already described
for whole kidney organ culture (Fig. 9A). Normal recombination,
with iterative UB branching, occurred in the presence of 2OS-
depleted heparin (despite the fact that isolated UB branching was
inhibited by 2OS-depleted heparin) with connecting segment
formation (white arrows in Fig. 9C). These data support the view
that MM induction is dependent upon factors that bind to 2-O
sulfated HS. Thus, the defect in the Hs2st null mouse leading to renal
agenesis mainly resides within the MM's ability to induce progres-
sion of the UB from the budding stage to the iterative branching
stage of nephrogenesis.
Discussion
We have utilized a novel combination of in vivo and in vitro
approaches to provide the ﬁrst clear example of a defect in the
transition of the ureteric bud (UB) from the ﬁrst dichotomous
branching step of kidney development to the iterative branching
phase as a consequence of a primary MM defect; this arises from
inadequate 2-O sulfation of heparan sulfate (HS) moieties. This step is
one of the limiting steps in early kidney collecting systemdevelopment,
Fig. 9. Effects of heparin and 2OS-depleted heparin on mesenchymal-to-epithelial transformation. (A) Confocal micrographs of embryonic kidney cultured for 4 days in the absence
(control) or presence of 100 μg/ml 2OS-depleted heparin or heparin. Note that addition of heparin results in generalized tissue death (A, far right panel) while addition of
2OS-depleted heparin (A, middle panel) inhibits UB branching but mesenchymal induction continues to take place at UB tips that do form (D. biﬂorus lectin (green) and E-cadherin
(red); arrow point to induced MM structures). (B) Phase contrast micrographs of metanephric mesenchyme (MM) isolated from E13 rat kidney co-cultured with spinal cord. MM
was cultured for 5 days in the absence (control, far left panel) or presence of 100mg/ml heparin (B, far right panel) or 2OS-depleted heparin (B, middle panel). Circled areas highlight
MM that has undergonemesenchymal-to-epithelial transition. (C) Effects of 2OS-depleted and fully sulfated heparin onmutual induction between the isolated UB andMM. Confocal
micrographs of isolated UB cultured for 7 days then recombined with freshly isolated MM and further cultured for 5 days in the absence (control) or presence of 100 μg/ml heparin
(C, far left panel) or 2OS-depleted heparin (C, middle panel) (D. biﬂorus (green) and peanut agglutinin (red) outline UB derived (green) andmesenchymal (red) structures). Note the
absence of induced MM structures including comma and s-shaped bodies in the heparin treated tissues and apparently normal MM induction in the presence of 2OS-depleted
heparin (arrowheads point to induced MM structures; arrows in higher magniﬁcation images (D) point to connecting segments between isolated UB and MM derived tissues).
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by the lack of HS 2-O sulfation in vitro or in vivo.
Heparan sulfate is a glycosaminoglycan abundantly present on the
cell surface, extracellular matrix and within the basement membrane.
Disruption of HS synthesis leads to embryonic lethality in mice (Lin
et al., 2000; Stickens et al., 2005), while disruption of HS sulfation has
a variety of developmental consequences on multiple different organ
systems (Bullock et al., 1998; Fan et al., 2000; Grobe et al., 2005; Li
et al., 2003; Shworak et al., 2002). The severe kidney phenotypes
associated with null mutation of Hs2st and C5 epimerase highlight the
centrality of HS sulfationmodiﬁcations to this developmental process.
Here, we have re-examined the in vivo phenotype and employed
several in vitro assays that recapitulate the stages of kidney
development to isolate the defect in the Hs2st null mouse that results
in renal agenesis. Quite surprisingly, when Hs2st null progenitor
tissues (Wolfﬁan duct (WD), UB and metanephric mesenchyme
(MM)) are cultured either in isolation, as with the WD or UB or in the
presence of wild-type HS, as with the MM, each is capable of
undergoing its speciﬁed developmental program; however, when
combinedwith tissue carryingmutant HS (either as embryonic kidney
culture or in UB-MM co-culture), these processes fail. That each can
develop in isolation suggests that the downstream intracellularsignaling pathways are intact and that it is likely the extracellular
environment that is unfavorable to kidney development.
To our knowledge, such a set of results has never been reported. It
has previously been suggested that the primary target for 2-O sulfated
HS is to primarilymodulate UB branching (Wilson et al., 2002). By using
variably sulfated heparinderivativeswe are able to demonstrate thatUB
branching is actually not strongly modulated by factors that depend on
2-O sulfated HS, although factors modulating mesenchymal-to-epithe-
lial transition in the MM are sensitive to the 2-O sulfation modiﬁcation.
Taken together these results demonstrate that the early cessation of
kidney development in the Hs2st−/− mouse is not the result of an
intrinsic defect within the UB but rather, most likely a primary
disturbance in the signaling of MM induction in vivo and in vitro, and
possibly also (at least in vitro) a failure of MMmorphogenesis.
One of the unexpected ﬁndings of this study was that in
approximately 30% of embryos, the UB had undergone the ﬁrst
dichotomous branching event. We can only speculate that the reason
for the discrepancy in our observed phenotype from that which was
originally reported (Bullock et al., 1998) is due to the laboratory
timing of embryonic development, which can vary from experiment
to experiment and lab to lab by half a day, thereby leading to
somewhat different results. Irrespective of the reason, the ﬁnding
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factor(s) that stimulate the unbranched UB to undergo the ﬁrst
dichotomous branching step.
Another surprising ﬁndingwas the ability of mutant UB andMM to
undergo their morphogenetic programs in the presence of wild-type
HS (Fig. 5). This resultwould seem to discount cell surfaceHS, either on
the UB or MM itself, as a primary modulator of these processes. It is
possible, however, that shedding of cell surface HSPGs in response
to extracellular cues (Selleck, 2006) provides a repository of
HS-associated growth factor within the matrix that may be important
to the inductive process; this mechanism would provide an explana-
tion ofwhywild-typeHS fromeither theUBorMMis adequate to drive
the system in vitro.
Alternatively, it has been proposed that HS presented in trans to a
growth factor receptor can compensate for loss of cell surface HSPGs,
such that local, cell-autonomous deﬁciencies in HS production can be
fully rescued by adjacent cells, thereby acting cell nonautonomously
(Kramer and Yost, 2002). This concept has recently been proven in
vascular morphogenesis. Complete loss of N-sulfated HS in the
basement membrane between endothelial cells and mural cells
abrogates VEGFR signaling in endothelial cells (Stenzel et al., 2009).
In the absence of endothelial cell-derived HS, N-sulfated HS produced
by mural cells is sufﬁcient to support VEGFR signaling in endothelial
cells (Jakobsson et al., 2006) illustrating that HS and growth factor
receptors can interact in trans in developmental processes. Hs2st itself
is expressed in both the UB and MM (Bullock et al., 1998), and HS is
found throughout the kidney but is present at highest concentrations
in the basement membrane that lies between the UB and MM (Davies
et al., 1995). Itmay be that HS presentwithin the basementmembrane
is necessary for high afﬁnity growth factor-growth factor receptor
interactions which transmit inductive signals to the UB. Alternatively,
these interactions may be part of an autocatalytic loop that functions
to amplify growth factor signals (Monte et al., 2007; Nigam and Shah,
2009). In the case of theHs2stnullmouse, it appears that appropriately
sulfated HS from either the UB or MM “in trans,” can compensate for
lack in the other compartment. These “in trans” 2-O sulfated HS may
be important in the growth factor-dependant inductive UB-MM
crosstalk necessary for early UB branching, and our cumulative data
argue that this is where the defect resides (on the MM side); thus
explaining the renal agenesis that occurs in the absence of Hs2st.
Interestingly, neither the UB nor MM isolated from Hs2st null
rudiments that had an unbranched UB was able to induce mesen-
chymal-to-epithelial transformation or branching morphogenesis
respectively. Thus, the cascade of inductive signals between the
undifferentiated metanephric mesenchyme and epithelial UB that
ﬁrst induce UB formation, then stimulate UB birfurcation and ﬁnally
bring about iterative UB branching appear to have varying sensitivity
to HS sulfation. The ﬁrst step, while likely to bemodulated (in part) by
heparin binding growth factors, involves molecules that are seem-
ingly not as dependent upon HS sulfation pattern while the factors
that move the unbranched UB towards bifurcation demonstrate a
signiﬁcant sensitivity to the HS 2-O sulfation modiﬁcation, whereas
those that modulate early UB branching are exquisitely sensitive.
HS 2-O sulfation has been demonstrated to be an essential
component for high afﬁnity HS binding for many factors important
to kidney development including GDNF. While GDNF has been shown
to primarily modulate UB branching (Qiao et al., 1999; Shakya et al.,
2005), complex interactions that lead to mesenchymal differentiation
have not been ruled out. Several studies suggest that GDNF bioactivity
demonstrates an unusually high dependence upon the presence of HS
2-O sulfates (Rickard et al., 2003; Davies et al., 2003). GDNF has been
shown to be necessary for formation of the UB from the WD and in
branch initiation (Sainio et al., 1997), and mice homozygous null for
GDNF predominantly display a phenotype of renal agenesis due to lack
of formation of the ureteric bud although a small proportion do
undergo rudimentary UB branching (Cacalano et al., 1998; Pichel et al.,1996; Schuchardt et al., 1994). Although the expression of GDNF is
rapidly downregulated inHs2st−/− kidney rudiments, the observation
that the majority of GDNF deﬁcient mice do not form a ureteric bud
suggests that HS 2-O sulfation is not an absolute requirement for GDNF
signaling in vivo since the UB forms in the absence of Hs2st (Wilson
et al., 2002). Alternatively, a recently described GDNF-independent
bypass pathway for UB budding may be operative (Maeshima et al.,
2007). This study supports these possibilities since budding and
branching occurs normally in Hs2st null WDs and UBs, respectively.
The question then remains, if not GDNF, what are other possible
factors involved in the Hs2st null phenotype? One possibility includes
members of the Wnt family of secreted molecules, which have been
shown to be important during mesenchymal-to-epithelial transition
(Schmidt-Ott et al., 2006). Wnt9b, expressed in the WD and its
derivatives, has been shown to be a primary modulator of mesenchy-
mal transformation. Knockout of Wnt9b results in renal agenesis with
intact ureter formation, a similar phenotype to that seen in Hs2st
mutants. Further analysis of Wnt9b null mice reveals that UB invasion
of theMMoccurs at the appropriate stage and theﬁrst branching event
is initiated; however mesenchymal induction fails and subsequent UB
branching is disrupted (Carroll et al., 2005). Similar to the Hs2st
mutant mouse, Wnt9b −/− mice have downregulated GDNF and
Wnt11 expression suggesting that the Wnt11-GDNF positive regula-
tion loop is disrupted (Majumdar et al., 2003). In certain respects, the
Hs2st−/− kidney can be viewed as the counterpart example to the
Wnt9b −/− kidney with the primary defect being on the MM rather
than WD/UB side but nevertheless, leading to a similar phenotype.
Wnts are known to be dependant upon HS for signaling (Lin, 2004);
thus these, along with other heparin binding growth factors known to
affect budding and branching (Bush et al., 2004;Maeshima et al., 2006;
Sakurai et al., 2001, 2005), are candidate signaling pathways that lead
to the renal agenesis phenotype.
In summary, this study utilizes a novel combination of in vivo and
in vitro analyses to dissect the potential roles of differential HS
sulfation during kidney development. Our analyses revealed involve-
ment of Hs2st in the advancement to the iterative UB branching stage
as a result of a primaryMMdefect in 2-O sulfation. The combination of
in vivo and in vitro strategies used here adds power to the analysis
that neither approach allows on its own. We use this combined
approach to show that the failure in kidney development in the Hs2st
mutant mouse is likely the result of inhibition of mutual inductive
signaling that occurs after WD budding and primarily resides in the
MM. This is in contrast to previous assertions suggesting a primary
role of sulfated HS in UB branching, rather than MM differentiation
(Wilson et al., 2002); of course, this hypothesis was reasonable in that
it was based on histology. A corollary of the combined in vivo/in vitro
approach lies in the observation that if, as this study suggests, the
inductive signal mediated by 2-O sulfated HS can be facilitated by
wild-type HS provided by either the UB or MM, then it is unlikely that
UB or MM speciﬁc knockout of Hs2stwould actually result in a kidney
phenotype and thus would not help to clarify the mechanism of
developmental failure; it was only through the separate modeling of
the stages of kidney development in vitro and titration of the activity
of factors that are involved in UB and MM morphogenesis in these
stages that we were able to identify the defect.
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